Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Das

Showing results (1061-1070 of 1,101) with videos related to

Pageof 111
Sort By:
JIMD Reports|April 22, 2014
Lysine-Restricted Diet as Adjunct Therapy for Pyridoxine-Dependent Epilepsy: The PDE Consortium Consensus RecommendationsClara D M van Karnebeek, Sylvia Stockler-Ipsiroglu, Sravan Jaggumantri, et al.
Memorias Do Instituto Oswaldo Cruz|June 15, 2007
In vitro inhibition of Plasmodium falciparum by substances isolated from Amazonian antimalarial plantsValter F de Andrade-Neto, Adrian M Pohlit, Ana Cristina S Pinto, et al.
Molecular Genetics and Metabolism|June 7, 2017
3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: Clinical presentation and outcome in a series of 37 patientsSarah Catharina Grünert, Sonja Marina Schlatter, Robert Niklas Schmitt, et al.
Journal of Inherited Metabolic Disease|December 4, 2020
Impact of interventional and non-interventional variables on anthropometric long-term development in glutaric aciduria type 1: A national prospective multi-centre studyE M Charlotte Märtner, Esther M Maier, Katharina Mengler, et al.
Respiratory Research|November 19, 2015
Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling studyP E Silkoff, I Strambu, M Laviolette, et al.
Science (New York, N.Y.)|September 18, 2010
IDH2 mutations in patients with D-2-hydroxyglutaric aciduriaMartijn Kranendijk, Eduard A Struys, Emile van Schaftingen, et al.
Journal of Medicinal Chemistry|March 18, 2005
Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potencyGeorge V De Lucca, Ui Tae Kim, Brian J Vargo, et al.
Human Mutation|July 13, 2006
Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessmentSonja C Stadler, Roman Polanetz, Esther M Maier, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2007
CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicityJames R Pruitt, Douglas G Batt, Dean A Wacker, et al.
Nature Communications|July 17, 2025
Integrative spatial omics reveals distinct tumor-promoting multicellular niches and immunosuppressive mechanisms in Black American and White American patients with TNBCQian Zhu, Akhila Balasubramanian, Jaya Ruth Asirvatham, et al.
Pageof 111

Showing results (1061-1070 of 1,101) with videos related to

Sort By:
Pageof 111
JIMD Reports|April 22, 2014
Lysine-Restricted Diet as Adjunct Therapy for Pyridoxine-Dependent Epilepsy: The PDE Consortium Consensus RecommendationsClara D M van Karnebeek, Sylvia Stockler-Ipsiroglu, Sravan Jaggumantri, et al.
Memorias Do Instituto Oswaldo Cruz|June 15, 2007
In vitro inhibition of Plasmodium falciparum by substances isolated from Amazonian antimalarial plantsValter F de Andrade-Neto, Adrian M Pohlit, Ana Cristina S Pinto, et al.
Molecular Genetics and Metabolism|June 7, 2017
3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: Clinical presentation and outcome in a series of 37 patientsSarah Catharina Grünert, Sonja Marina Schlatter, Robert Niklas Schmitt, et al.
Journal of Inherited Metabolic Disease|December 4, 2020
Impact of interventional and non-interventional variables on anthropometric long-term development in glutaric aciduria type 1: A national prospective multi-centre studyE M Charlotte Märtner, Esther M Maier, Katharina Mengler, et al.
Respiratory Research|November 19, 2015
Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling studyP E Silkoff, I Strambu, M Laviolette, et al.
Science (New York, N.Y.)|September 18, 2010
IDH2 mutations in patients with D-2-hydroxyglutaric aciduriaMartijn Kranendijk, Eduard A Struys, Emile van Schaftingen, et al.
Journal of Medicinal Chemistry|March 18, 2005
Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potencyGeorge V De Lucca, Ui Tae Kim, Brian J Vargo, et al.
Human Mutation|July 13, 2006
Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessmentSonja C Stadler, Roman Polanetz, Esther M Maier, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2007
CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicityJames R Pruitt, Douglas G Batt, Dean A Wacker, et al.
Nature Communications|July 17, 2025
Integrative spatial omics reveals distinct tumor-promoting multicellular niches and immunosuppressive mechanisms in Black American and White American patients with TNBCQian Zhu, Akhila Balasubramanian, Jaya Ruth Asirvatham, et al.
Pageof 111